Literature DB >> 4048968

Theoretical and experimental bases of intraperitoneal chemotherapy.

R L Dedrick.   

Abstract

Pharmacokinetic theory predicts that a large and potentially exploitable concentration difference occurs between the peritoneal cavity and the plasma after many anticancer drugs are administered intraperitoneally in large volume. Unresolved issues remain, particularly concerning the depth of penetration of drugs into tumor nodules growing on peritoneal surfaces. Recent studies in the rat showed a steep concentration gradient of small marker molecules in a variety of normal tissues. The concentration in the stomach and small and large intestines decreased to 10% of the value at the serosal surface in about 0.5 mm or less. Human serum albumin showed deeper penetration, particularly in the diaphragm and anterior abdominal wall.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4048968

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  35 in total

1.  Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy.

Authors:  Robert D Becher; Perry Shen; John H Stewart; Greg Russell; Joel F Bradley; Edward A Levine
Journal:  J Gastrointest Oncol       Date:  2011-06

2.  Evaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.

Authors:  Allyson M Womack; Andrea Hayes-Jordan; Rajarshi Pratihar; Denise A Barringer; James H Hall; Paul W Gidley; Jan S Lewin
Journal:  Ear Hear       Date:  2014 Nov-Dec       Impact factor: 3.570

3.  A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.

Authors:  Meiqin Yuan; Zeng Wang; Guinv Hu; Yunshan Yang; Wangxia Lv; Fangxiao Lu; Haijun Zhong
Journal:  Mol Clin Oncol       Date:  2016-06-02

4.  Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy.

Authors:  S J Valle; N A Alzahrani; W Liauw; P H Sugarbaker; A Bhatt; D L Morris
Journal:  Indian J Surg Oncol       Date:  2016-02-05

Review 5.  Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer.

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Oliver Zivanovic; Dennis S Chi
Journal:  Int J Hyperthermia       Date:  2017-08       Impact factor: 3.914

Review 6.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence.

Authors:  Wim P Ceelen; Michael F Flessner
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675

7.  Anesthesia and Pain Management for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors in Children, Adolescents, and Young Adults.

Authors:  Doralina L Anghelescu; Christina-Lin Brown; Andrew J Murphy; Andrew M Davidoff; Paxton V Dickson; Evan S Glazer; Zachary E Stiles; Michael W Bishop; Luke Douthitt; Jeremiah L Deneve
Journal:  Ann Surg Oncol       Date:  2018-10-23       Impact factor: 5.344

Review 8.  Update on the management of malignant peritoneal mesothelioma.

Authors:  Paul H Sugarbaker
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 9.  The role of the diaphragm in lymphatic absorption from the peritoneal cavity.

Authors:  M F Abu-Hijleh; O A Habbal; S T Moqattash
Journal:  J Anat       Date:  1995-06       Impact factor: 2.610

10.  Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis.

Authors:  Yu Chen; Wei-Feng Tang; Jing Lin; Yi Shi; Xiao-Jie Wang; Qiang Chen; Zeng-Qing Guo
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.